Neurology Minute

In part two of this series, Dr. Stacey Clardy and Dr. Justin Abbatemarco discuss the household exposures clinicians should consider when a patient receiving B-cell therapy develops fever, confusion, or new difficulty walking.

Show citation:

Abbatemarco JR, Begum F, Villalba JA, et al. Establishing Potosi Virus as a Human Pathogen: Fatal Neuroinvasive Disease in a B-Cell-Depleted Patient. Neurology. 2026;107(10):e218683. doi:10.1212/WNL.0000000000218683

In the second episode of this series, Dr. Derek Stitt discusses Glossopharyngeal neuralgia and nervus intermedius neuralgia, two types of cranial neuralgia.

In part one of this series, Dr. Derek Stitt discusses trigeminal neuralgia and, more specifically, how to make sure that's actually the diagnosis.

In this episode, Dr. Jose Posas reviews the Capitol Hill Report from October 26th, discussing international medical graduates, the Conrad 30 program, and the AAN's efforts to strengthen visa pathways for physicians serving communities across the US.

Stay updated with what's happening on the hill by visiting aan.com/chr.

Learn how you can get involved with AAN advocacy.

In part two of this series, Dr. Dara Albert and Isaac Thorman discuss guidance for parents weighing whether to let their children play tackle football.

Show citation:

Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:10.1212/CPJ.0000000000200656

In part one of this series, Dr. Dara Albert and Isaac Thorman discuss football as a major contributor to pediatric traumatic brain injury and its association with subsequent head injuries.

Show citation:

Thorman IB, Feldstein E, Sacknovitz A, et al. Youth Football and the Epidemic of Pediatric Brain Injury: Neurologic and Psychiatric Outcomes in a Cohort of 72,025 Concussions. Neurol Clin Pract. 2026;16(6):e200656. doi:10.1212/CPJ.0000000000200656

Dr. Justin Abbatemarco discusses an article that helps us distinguish between the causes of acute optic neuropathy.

Show citation:

Tisavipat N, Stiebel-Kalish H, Palevski D, et al. Acute Optic Neuropathy in Older Adults: Differentiating Between MOGAD Optic Neuritis and Nonarteritic Anterior Ischemic Optic Neuropathy. Neurol Neuroimmunol Neuroinflamm. 2024;11(3):e200214. doi:10.1212/NXI.0000000000200214

Dr. Aaron Zelikovich discusses how gefurulimab may offer an effective and convenient treatment option for adults with generalized myasthenia gravis.

Show citation:

Gwathmey KG, Saccà F, Howard JF Jr, et al. Efficacy and Safety of Gefurulimab in Generalized Myasthenia Gravis: The PREVAIL Phase 3 Randomized Clinical Trial. JAMA Neurol. 2026;83(9):841-850. doi:10.1001/jamaneurol.2026.2333

Dr. Andy Southerland and Dr. Matthew Gusler discuss how emergent interfacility transfers for ischemic stroke have changed and the factors associated with which patients are transferred.

Show citation:

Gusler MT, Deligkaris C, Zha AM, Burke JF. Trends in Emergent Interfacility Ischemic Stroke Transfers, 2016-2022. Neurology. 2026;107(7):e218499. doi:10.1212/WNL.0000000000218499